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Abstract 
The nuclear hormone receptors (NHRs) are important features of the cell, as they 
control activities of cell development, homeostasis, reproduction, and 
metabolism.  Importantly, NHRs are also targets for naturally occurring and synthetic 
endocrine disrupting compounds. Any interference with their functioning has been 
connected to breast cancer, decreased fertility, osteoporosis, and other disorders in 
humans and other animals. We have constructed a very simple reporter system, or a 
biosensor, by modifying Escherichia coli by inserting an intein with the beta subtypes of 
the human estrogen receptor ligand-binding domain and thymidylate synthase reporter 
enzyme gene (D1210). With this modification, these E. coli cells can sense human 
estrogen and report their presence and interactions through changes in growth 
phenotype. The modified E. coli cells are referred to as biosensors and they have 
capabilities to distinguish estrogen agonistic growth and antagonistic suppression 
activities and report rough estimates of binding affinity. In this study, we will be 
conducting experiments to investigate the interactions of plant-derived estrogens, or 
phytoestrogens, and their estrogenic potency. In order to generate the data, biosensor 
cells are cultured in thymine-less media, and are introduced to test ligands. The 
biosensor growth phenotype allows the identification of which phytoestrogens will yield 
a similar potency to estrogen. The growth phenotype were determined by measuring the 
optical density (OD600) at wavelength of 600 nm. Our experiment results suggest that 
genistein and daidzein, which belongs to the category of isoflavones, yield similar 
potencies as estrogen. Comparisons between the tested phytoestrogens binding affinity 
were also studied and reported. While the estrogenic potency of industrial-originated 
estrogenic compounds is very limited, the findings of this study can hopefully reveal the 
estrogenic potency of phytoestrogens and also reveal what may trigger many of the 
biological responses that are evoked by the phytoestrogens and its ability to be a 
potential remedy for advanced endocrine related cancer.  
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Introduction 
The nuclear hormone receptors (NHRs) are a family of ligand-activated 
transcription factors present in animals. [1] NHRs control the expression of several genes 
as a response to the presence of hormones and hormone-like compounds. Some of the 
well-known members of this receptor superfamily are estrogen, androgen, thyroid 
hormone, progesterone receptors and more endocrine-related receptors. [4, 6] Nuclear 
hormone receptors is made up of very important classes of broad drug targets. [1] This is 
because NHRs have been linked to variety spectrums of diseases such as leukemia, 
breast cancer, endometrial cancer, prostate cancer, cardiovascular disease, 
osteoporosis, and inflammations. [2, 3] Thus, a discovery of novel compounds with ability 
to bind and modulate these receptors could lead to the development of valuable 
therapeutics against serious pathological conditions.[4, 6]  The current method uses 
screenings of identifying hormonal compounds that exists as a form of in vitro 
competitive binding assays. Known as E-screen, this method observes the proliferation 
of human breast cancer cells in the presence of test compounds and evaluate their 
estrogenicity.[7] However, this method is not appropriate for the construction of high-
throughput screening systems.[7] Furthermore, these approaches of utilizing animal cell-
assays are generally complex, time-consuming, and expensive.[7] Another method that 
utilizes biosensor is known as Biacore T100. The Biacore T100 is a Surface Plasmon 
Resonance based biosensor for detecting, characterizing, and quantifying bimolecular 
interactions. The Biacore T100 employs a modified gold surface on which a ligand is 
immobilized. The sample analyses is then injected over this surface using an automated 
microfluidics system. Binding results in an increase in mass on the surface which is 
recorded as a change in instrument response over time (www.biocore.com). However, 
Biacore T100 is expensive and time consuming. Thus, a cheaper method must be 
constructed and utilized in order to accelerate the lead identification process and 
allowing new drugs to be discovered. This may be done with a construction of a simple 
in vivo assays using yeast or bacteria biosensor. [4, 6] 
The ligand-binding domain (LBD) of the nuclear hormone receptors has shown to 
possess the ability to act as post-translational functional switches for a number of 
heterologous proteins when included as insertion fusions. [8,9] Furthermore, binding 
domains derived from the estrogen, androgen, and thyroid hormone receptors have 
been used to convey hormone-regulated activity to transcription factors, and other 
reporter protein such as dihydrofolate reductase (DHFR) and more.[4,8,9] This 
characteristics has been employed to develop many of the currently used in vivo 
screening strategies for endocrine modulators and also as a tool for deciphering 
different aspects of different hormone-regulated endocrine pathways in eukaryotes [4, 5]. 
However, the question of whether this property can be applied to the construction of 
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simple bacterial systems for high-throughput screening of test compounds remains 
unknown.   
A recent publication in the journal of environmental toxicology (Gierach et al.) 
have reported a successful construction of a novel recombinant bacterial biosensor 
protein that includes a human, pig, and sole NHR LBD, which these LBDs are stabilized 
by an engineered mini-intein splicing domain and joined to a thymidylate synthase (TS) 
reporter enzyme. [4, 6] This bacterial biosensor undergoes conformational changes 
depending on either agonistic and antagonistic binding to the human, sole, or pig ERβ 
LBD. Subsequently, this binding leads to inducing a change in the TS reporter enzyme 
activity. Since TS acts as a catalyst of the methylation of deoxyuridylate to 
deoxythymidylate using 5, 10-methylenetetrahydrofolate (methylene-THF) as a cofactor 
and effects synthesis of thymine, the change in TS activity is shown by a change in 
growth phenotype of the E. coli cells, which can be quantified by growth measurements 
in a high-throughput format.[6, 11] TS is a crucial enzyme for the growth of biosensor cells 
because TS enzymes synthesize thymine in the biosensor cells, which is one of the four 
nucleobases in the nucleic acid of DNA. Without this TS gene (D1210), thymine will not 
be produced. This leads to termination of DNA replication, and subsequently eliminating 
the proliferation of the biosensor cells. This biosensor cell cultures are developed 
initially without the testing ligand during overnight/overday cultures; thus, we assume 
that the TS fusion proteins on the sensor module are inactive. When the modules are 
inactive, biosensor cells are not healthy and cannot proliferate. To overcome this 
problem, thymine is supplemented to cell cultures for the DNA replication and 
proliferation. Addition of thymine in cell cultures results in proliferation of cells that are 
healthy enough for biosensor tests. These bacterial biosensors also inform more 
information of the test compounds due to its ability to recognize the difference between 
agonist and antagonist. [5] 
Another previously constructed estrogen binding sensor was constructed using 
Saccharomyces cerevisiae, which also provides guidelines for the construction of a 
simple screening assays [5]. This system reports the presence of active estrogen-alike 
compounds through growth phenotype on a selective medium [10]. This sensor is based 
on a chimeric fusion of the ligand-binding domain of the human estrogen receptor with 
temperature-sensitive mutants of dihydrofolate reductase (DHFR). Thus, DHFR-
deficient yeast strains are able to grow at elevated temperatures only in presence of 
estrogen, which allows estrogen-alike compounds to be identified easily through 
phenotypical changes. This yeast assay was able to successfully detect estrogen 
analogues from a small library of test compounds. With advantages in speed and 
simplicity, this system offers the advantage that it can be adapted to accommodate 
different binding domains. Because of this, this yeast assay offers a general tool for 
reporting ligand-receptor interactions. However, one of the main shortcomings of this 
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yeast assay has been their inability to recognize the biological role of a test compound. 
For example, yeast assays has been shown to unable to discriminate reliably between 
agonistic and antagonistic effects of synthetic hormone mimics [5]. 
In this study, we describe the methods and results of bacterial sensors of nuclear 
hormone binding when induced by well-known phytoestrogens, estrogens, and other 
endocrine disrupters. The ligand-binding domain of the human estrogen β (ERβ), in 
combination with a stabilization and a solubilization domain, was fused to a TS enzyme. 
Expression of this fusion protein in TS-deficient Escherichia coli strains resulted in 
specific hormone-dependent phenotypes, which could be detected readily through 
changes in cell growth on selective thymine-free medium (-THY). [4, 6] On the previously 
reported study (Gierach et al.), several known hormone antagonists were to neutralize 
the effects of known agonist compounds on cell growth when added in combination, 
which indicates that this sensor is able to distinguish between antagonistic and agonistic 
activities [4]. Thus, it is expected that this bacterial biosensor will be an attractive 
alternative for performing the initial chemical compound library screening for the 
identification of compounds with potential therapeutic actions against serious diseases. 
[4, 6]  
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Design and plasmid construction of a hormone-sensing ERβ 
biosensor protein 
 The design of the hormone-sensing biosensor protein is built on the principle of 
coupling the hormone-depending regulatory function of the LBD of a provided nuclear 
hormone receptor with the activity of the well-characterized TS enzyme. [4, 6] The activity 
of this biosensor cells can be monitored easily by measuring the growth phenotype in 
TS-knockout cells[11], and it has been used in several previously reported genetic 
selection systems.[12, 13] Because the amount of active TS required for growth increases 
proportionally with the incubation temperature, this bacterial biosensor protein system 
provides an accurate and quantitative measurement of TS enzyme activity by simply 
testing growth phenotypes over a range of temperatures [11-13] The expression of nuclear 
hormone-binding domains in E. coli is usually hindered by low solubility and poor 
stability; however, these problems can be avoided by the use of various gene fusions.[5, 
14-18] Thus, stabilization and solubilization domains are included as parts of the 
constructed fusion.[5] This stabilization domain consists of a previously isolated mini 
splicing domain of the Mycobacterium tuberculosis RecA intein (Mtu intein).[5] Many 
derivative of this intein has been reported to fold properly and maintain activity when 
inserted into foreign protein hosts, [19] and can tolerate the genetic insertion of non-
native short polypeptides [20] or entire folded protein domains. [21-24]  
Previous works in Dr. Wood laboratory have indicated that the insertion of the 
ligand-binding domain of a nuclear hormone receptor into mini intein splicing domain 
allows the binding domain to adopt its correct fold and maintain its binding ability in E. 
coli. [4, 24]  Additionally, including the maltose-binding protein tag (MBP) may increase the 
solubility and activity of the chimeric fusion. [25] Schematic representation of human, 
sole, and porcine biosensor genes are shown in figure 1 below. Notations are as 
follows: Ptac* = mutant tac promoter associated with hormone dependent phenotype; 
MBD = Maltose Binding Domain; N-Mtu = 5 first 110 residues of the Mycobacterium 
tuberculosis RecA intein; ERB = Estrogen Receptor B subtype ligand-binding domain; 
C-Mtu = last 58 residues of the Mtu RecA intein; TS = bacteriophage T4 thymidylate 
synthase enzyme. [4] Note that schematic representations of rat, cow, and zebra fish 
genes are not shown. 
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 Figure 2. Schematic representations of human, sole, and porcine biosensor 
genes.    
 
With these guidelines, endonuclease domain of the wild-type Mtu intein was 
replaced with estrogen receptors (ER) to form the initial chimeric fusion.[5] Splicing and 
N-terminal cleavage by the intein were suppressed by mutation of its initial amino acid 
from cysteine to alanine, while C-terminal cleavage was prevented by substituting the 
ultimate asparagine residue with alanine.[5, 12, 13] The established chimeric intein was 
fused to the N-terminus of the bacteriophage T4 td gene and the resulting fusion was 
cloned into plasmid pMal-c2 as a C-terminal fusion to the E.coli maltose binding 
domain.[5, 13]  The T4 TS enzyme is known to complement TS-knockout bacterial cells; 
however, the td gene will not recombine with E. coli chromosomeal thyA gene.[13] The 
result of this construction is referred to as pMIT::ER (artificial tac promotor-MBP-intein-
ts::estrogen receptor).[4,6] E coli D1210ΔthyA cells, which are deficient in native TS, 
were transformed with pMIT::ER and reported to unable to grow at all temperatures 
tested in a thymine-free medium, regardless of the presence of estrogen.[5]  
Thus, the plasmid pMIT::ER was introduced into E. coli XL1-Red for the 
introduction of random mutations that might impart hormone sensitivity. This mutant was 
selected in E coli D1210ΔthyA for growth on thymine-free agar plates (TS+ phenotype) 
in the presence and absence of 17-β-estradiol (E2). After incubation, colony formation 
was observed to become estrogen-sensitive on plates incubated at 30°C. [5] It is shown 
that several of the mutants that exhibited TS+ phenotypes were sequenced and all were 
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found to contain a G to A nucleotide substitution in the lac operator region, 16 bases 
downstream of the TATAA motif of the tac promoter. [4, 6] No other mutations were 
observed and this suggests that that the observed positive phenotype is based on 
changes in expression level, most likely due to reduced affinity of the lac repressor for 
this recognition sequence. [5] 
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Experimental Methods and Statistical Analysis of Results 
Test compounds that were used in various experiments are 17-β-estradiol (E2), 
5,7-Dihydroxy-3-(4-hydroxyphenyl)chromen-4-one (Genistein), 7-Hydroxy-3-(4-
hydroxyphenyl)chromen-4-one (Daidzein), 5,7-dihydroxy-3-(4-methoxyphenyl)chromen-
4-one (Biochanin A), 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one 
(Apigenin), dimethyl sulfoxide (DMSO), and 4,4’-isopropylidenediphenol (BPA). These 
chemical were purchased from Sigma (St. Louis, MO, USA). The plasmas of all species 
to be tested were provided by Dr. David W. Wood (Ohio State University, Department of 
Chemical and Biomolecular Engineering). All other chemicals used for microbial cell 
culture were purchased from Fisher Scientific (Pittsburgh, PA, USA).  
The design of the human, pig, sole, cow, rat, and zebra fish are referred to as 
pMIT::ERβ*(h), pMIT::ERβ*(p), pMIT::ERβ*(s), pMIT::ERβ*(c), pMIT::ERβ*(r), and 
pMIT::ERβ*(zf), respectively. These plasmids of different pMIT:: ERβ* have been 
transformed into the E. coli strain D1210ΔthyA::KanR [F--Δ(gpt-proA)62 leuB6 supE44 
ara- 14 galK2 lacY1 Δ(mcrC-mrr) rpsL20 (Strr) xyl-5 mtl-1 recA13 lacIq] and plated cells 
on Luria-Bertani (LB) medium agar[4, 6]. The LB agar plate is supplemented with 100 
µg/mL ampicillin and 50 µg/mL thymine. After all strains are plated, plates are 
transferred to an air incubator that is maintained at 37°C for colonies to grow. Figure 2 
below illustrates plates after incubation at 37°C. 
 
Figure 2. A picture of plates after air incubation maintained at 37°C.  
Fresh colonies contacting the appropriate biosensor plasmid are introduced to a 
fresh 5 mL of LB liquid media in a tube that is supplemented with 100 µg/mL ampicillin 
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and 50 µg/mL thymine. After, tubes are transferred to water bath shaker that is 
maintained at 37°C and are grown over night for 15 hours. A picture of before and after 
of overnight procedure is shown in figure 3 below.  
 
 
Figure 3. Before and after picture of biosensor cells from left to right, respectively. 
Next, the overnight growth assays are transferred into fresh set of growth 
medium containing 5 mL of liquid LB, 125 µL of thymine, 5 µL of ampicillin and 50 µL of 
appropriate pMIT::ERβs cells. They were placed in the water bath shaker for about 4 
hours or until they reach optical density of 1.3 to 1.5. These seed cultures were then 
diluted 1:200 in liquid thymine-free medium (-THY) (per liter: 10 ml of 10% casamino 
acids; 10 ml of 20% glucose; 200 ml of 1% thiamine HCl; 200 ml of 5! Minimal Broth, 
Davis (MBD: 35 g dipotassium phosphate, 10 g monopotassium phosphate, 2.5 g 
sodium citrate, 0.5 g magnesium sulfate, and 5 g ammonium sulfate, per liter); 10 ml of 
Thy Pool (2 mg/ml of each of the following amino acids: L-Arg, L-His, L-Leu, L-Met, L-
Pro, and L-Thr); and 1 ml of 0.1 M CaCl2, pH 7.0) supplemented with 100 mg/ml 
ampicillin.[26] For growth assays, 200 mL of the diluted cells were transferred into each 
well of a 96-well microtiter plate, and each well was supplemented with 2 ml of test 
compounds dissolved in dimethyl sulfoxide (DMSO). The concentration of the test 
compound in DMSO was adjusted such that the total concentration of DMSO in each 
well was the same and only the concentration of test compounds changed for purpose 
of producing dose-response curve fittings and calculating half maximal effective 
concentration (EC50) of each test compound. The 96-well microtiter plates were then 
incubated at 34°C, 150 rpm agitation, and 80 percent humidity for 16-24 hours.[26] 
Growth phenotypes of biosensor cells were then measured corresponding optical 
absorbance at a wavelength of 600 nanometers (OD600) by utilizing Biotek Synergy 2 
plate reader. All the bacterial assays were carried out in duplicate and were additionally 
repeated two times on two different days. The normalized growth signal is the difference 
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between the OD600 value in the presence of a test compound and that in the presence 
of pure DMSO control for each strain.[4, 6, 26] The EC50 values was determined by fitting 
the growth data to equation (1), where X is the test compound concentration, Y is the 
observed growth signal (OD600), and Bottom, Top, EC50, and Hillslope are the fitted 
parameters. The fitting was carried out with non-linear regression fitting by using the 
software package GraphPad Prism 5.01 (www.graphpad.com)[4, 6, 26].  
𝑌𝑌 = 𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵 +  𝑇𝑇𝐵𝐵𝑇𝑇 − 𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵1 + 10log(𝐸𝐸𝐸𝐸50−𝑋𝑋)×𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻             (1) 
The statistical significances (P-value) between the OD600 and EC50 were 
determined by using t-test function (two-tailed, two-sample equal variance) in jmp 
software (www.jmp.com). Relative pseudotransactivation (RPTA) values for each test 
compounds are calculated by using equation (2), where ECE250 is the half maximal 
effective concentration of 17-β- estradiol, and ECligand50 is the half maximal effective 
concentration of test compound. [4, 6] 
𝐸𝐸𝐸𝐸50
𝐸𝐸2/ 𝐸𝐸𝐸𝐸50
𝐻𝐻𝐻𝐻𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙             (2) 
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Results 
Detection of Estrogen with Current Biosensors 
To test if phenotypic changes can be made by ERβ biosensors when EDCs are 
present, current biosensors were tested with E2, which is one of well-known EDCs. 
Positive control consists of E2 with DMSO and negative controls consist of DMSO and 
no ligand. For this control experiment, only biosensors of human (pMIT::ERβ*(h)), sole 
(pMIT::ERβ*(s)), and porcine (pMIT::ERβ*(p)) were employed. OD600 of each strains 
with its positive and negative controls were calculated by GraphPad Prism 5.01 and are 
shown in figure 4 below. All of the positive and the negative control OD600 result with 
all of available strains are reported in appendix I.  
  
 
 
 
 
 
 
 
Figure 4. Dose-response curves of pMIT::ERβ – Human, Porcine, and Sole. 
Curves were generated through non-linear regression fitting by GraphPad Prism 
5.01 software. Notations are as follows: E2 = 17-β-estradiol, NO = no test ligand, 
DMSO = dimethyl sulfoxide 
15 
 
When these biosensors are induced with E2, their growth phenotype changes 
were observed across these 3 different species. Thus, EC50 of E2 for human, sole, and 
porcine biosensors were able to be calculated. However, no significant growth 
phenotype changes were observed when biosensors were induced with DMSO and no 
test compound. As a result, EC50 could not be accurately calculated.   
Comparison of Current Biosensors 
EC50 and OD600 measurements of E.coli biosensor of pMIT::ERβ*(h), 
pMIT::ERβ*(s), and pMIT::ERβ*(p), were compared with previously reported values for 
validation purposes. Table 1, 2, and 3 below shows the previously reported values 
(Gierach et al., 2011) and two other experimental values, respectively.  
 
Table 1. Prevously Reported EC50 and RPTA Values from Journal of 
Enviormental Toxicology (Gierach et al.) of Human, Porcine, and Sole Biosensor 
with E2, Daidzein and BPA in 2011.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ligand EC50 (µM) CI (µM) R Square RPTA(%)
E2 0.015 0.00675 to 0.033 0.900 100
Daidzein 0.360 0.131 to 0.983 0.870 4.17
BPA 1.700 0.183 to 17.4 0.820 0.882
Ligand EC50 (µM) CI (µM) R Square RPTA(%)
E2 0.016 0.013 to 0.0192 0.990 100
Daidzein 0.410 0.397 to 0.535 0.980 3.90
BPA 6.900 4.88 to 9.71 0.990 0.232
Ligand EC50 (µM) CI (µM) R Square RPTA(%)
E2 0.056 0.0209 to 0.153 0.860 100
Daidzein 6.000 3.25 to 11.4 0.910 0.933
BPA 1.000 0.107 to 9.85 0.860 5.60
Sus scrofa  (Porcine) - Reported
Solea solea  (Sole) - Reported
Homo sapien  (Human) - Reported
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Table 2. First Experimental Values of EC50 and RPTA of Human, Porcine, and 
Sole Biosensor with E2, Daidzein and BPA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ligand EC50 (µM) CI(µM) R Square RPTA(%)
E2 0.012 0.003 to 0.045 0.921 100
Daidzein 0.332 0.146 to 0.755 0.963 3.74
BPA 1.160 0.626 to 2.15 0.977 1.070
Ligand EC50 (µM) CI(µM) R Square RPTA(%)
E2 0.020 0.0112 to 0.0337 0.984 100
Daidzein 0.571 0.424 to 0.769 0.995 3.42
BPA 7.103 4.75 to 10.6 0.990 0.275
Ligand EC50 (µM) CI(µM) R Square RPTA(%)
E2 0.047 0.00274 to 0.0810 0.698 100
Daidzein 9.865 0.840 to 11.6 0.717 0.478
BPA 1.144 0.816 to 5.60 0.772 4.12
Homo sapien (Human) - Experimental 1
Sus scrofa  (Porcine) - Experimental 1
Solea solea  (Sole) - Experimental 1
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Table 3. Second Experimental Values of EC50 and RPTA of Human, Porcine, and 
Sole Biosensor with E2, Daidzein and BPA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
From previously reported values, calculated EC50, 95% CI, and R2 values are as 
follows: For (a) E2, Human EC50 = 0.015 µM (95% CI: 0.0067 µM to 0.033 µM; R2: 
0.900); Porcine EC50 = 0.016 µM (95% CI: 0.013 µM to 0.019 µM; R2: 0.990); Sole 
EC50 =  0.056 µM (95% CI: 0.021 µM to 0.153 µM; R2: 0.860 ); For (b) Daidzein,  
Human EC50 = 0.360 µM (95% CI: 0.130 µM to 0.980 µM; R2: 0.870); Porcine EC50 
=0.410 µM (95% CI: 0.390 µM to 0.535 µM; R2: 0.980); Sole EC50 =  6.00µM (95% CI: 
3.25 µM to 11.0 µM; R2: 0.910); and for (c) BPA, Human EC50 = 1.70 µM (95% CI: 
0.180 µM to 17.0 µM; R2:0.820); Porcine EC50 = 6.90 µM (95% CI: 4.88 µM to 9.71 µM; 
R2: 0.990 ); Sole EC50 =  1.00 µM (95% CI: 0.100 µM to 9.85 µM; R2: 0.860).  
For the reported first experimental values, EC50, 95% Confidence Interval, and 
R2 values are as follows: For (a) E2, Human EC50 = 0.012 µM (95% CI: 0.003 µM to 
0.045 µM; R2: 0.921); Porcine EC50 = 0.020 µM (95% CI: 0.011 µM to 0.034 µM; R2: 
0.990); Sole EC50 =  0.047 µM (95% CI: 0.003 µM to 0.081 µM; R2: 0.698); For (b) 
Daidzein,  Human EC50 = 0.332 µM (95% CI: 0.146 µM to 0.755 µM; R2: 0.963); 
Porcine EC50 =0.571 µM (95% CI: 0.424 µM to 0.769 µM; R2: 0.980); Sole EC50 =  
9.86µM (95% CI: 0.840 µM to 11.6 µM; R2: 0.717); and for (c) BPA, Human EC50 = 
1.16 µM (95% CI: 0.626 µM to 2.15 µM; R2: 0.977); Porcine EC50 = 7.10 µM (95% CI: 
Ligand EC50 (µM) CI R Square RPTA(%)
E2 0.018 0.0107 to 0.0287 0.987 100
Daidzein 0.357 0.235 to 0.528 0.991 4.90
BPA 2.108 1.34 to 3.32 0.987 0.831
Ligand EC50 (µM) CI R Square RPTA(%)
E2 0.017 0.0113 to 0.0266 0.991 100
Daidzein 0.973 0.538 to 1.76 0.979 1.78
BPA 6.494 4.19 to 10.1 0.988 0.267
Ligand EC50 (µM) CI R Square RPTA(%)
E2 0.045 0.00709 to 0.279 0.847 100
Daidzein 6.261 5.33 to 7.36 0.998 0.711
BPA 1.365 0.949 to 1.96 0.992 3.26
Solea solea  (Sole) - Experimental 2
Sus scrofa  (Porcine) - Experimental 2
Homo sapien  (Human) - Experimental 2
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4.75 µM to 10.6 µM; R2: 0.990 ); Sole EC50 =  1.14 µM (95% CI: 0.816 µM to 5.60 µM; 
R2: 0.772). 
For the reported second experimental values, EC50, 95% Confidence Interval, 
and R2 values are as follows: For (a) E2, Human EC50 = 0.018 µM (95% CI: 0.011 µM 
to 0.0287 µM; R2: 0.987); Porcine EC50 = 0.017 µM (95% CI: 0.0113 µM to 0.0266 µM; 
R2: 0.991); Sole EC50 =  0.045 µM (95% CI: 0.007 µM to 0.279 µM; R2: 0.847); For (b) 
Daidzein,  Human EC50 = 0.357 µM (95% CI: 0.235 µM to 0.528 µM; R2: 0.991); 
Porcine EC50 =0.973 µM (95% CI: 0.538 µM to 1.76 µM; R2: 0.979); Sole EC50 =  6.26 
µM (95% CI: 5.33 µM to 7.36 µM; R2: 0.998); and for (c) BPA, Human EC50 = 2.11 µM 
(95% CI: 1.34 µM to 3.32 µM; R2: 0.987); Porcine EC50 = 6.49 µM (95% CI: 4.19 µM to 
10.1 µM; R2: 0.988 ); Sole EC50 =  1.37 µM (95% CI: 0.949 µM to 1.96 µM; R2: 0.992). 
Comparison between experimental values with the previously reported values 
were made and all of the values fall within the 95% confidence intervals of 
corresponding strains and its test compounds. For experimental values, RPTA 
precedence from the highest to lowest percentages are as follows: for Human and 
Porcine, E2 > Daidzein > BPA; for sole, E2 > BPA > Daidzein. This estrogenic potency 
precedence is the same with previously reported values.  
Detection of Phytoestrogens 
   Phytoestrogens were used to induce the growth phenotype changes across 
E.coli biosensors of human, porcine, cow, rat, zebra fish, and sole. Dose-response 
curves are shown in figures 5 – 10 on the next page. Tables of calculated EC50 of 
phytoestrogens are shown in appendix II.  
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 Figure 8. A dose-response curve of rat ERβ biosensor 
induced with various phytoestrogens 
Figure 7. A dose-response curve of porcine ERβ 
biosensor induced with various phytoestrogens 
Figure 5. A dose-response curve of human ERβ 
biosensor induced with various phytoestrogens 
Figure 6. A dose-response curve of cow ERβ biosensor 
induced with various phytoestrogens 
Figure 9. A dose-response curve of zebra fish ERβ 
biosensor induced with various phytoestrogens 
Figure 10. A dose-response curve of sole ERβ biosensor 
induced with various phytoestrogens 
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Discussion 
Biosensor 
 In this study, an innovative approach for examining differences in agonistic ligand 
effects on the estrogen receptor β (ERβ) ligand binding domain derived from human, 
porcine, cow, rat, sole, and zebra fish were investigated. The key components of these 
methods are the engineered allosteric biosensor fusion proteins that are coupled with 
the thymidylate synthase (TS) reporter system. Previously, Dr. David W. Wood’s group 
have demonstrated that these biosensors are capable of recognizing hormone-like 
compounds for various human NHR targets and can differentiate between agonistic and 
antagonistic compounds. [4, 6]    
 This biosensor system is very distinct from conventional transactivation assays, 
which require the presence of coregulators and detection systems for various reporter 
genes. [6]  However, coregulators are not present in our system. Thus, ligand binding to 
the ERβ LBD produces a conformational change, which can be quantified by the TS 
reporter effects on phenotype. [4, 6]  Furthermore, we can refer our system as a 
pseudotransactivation assay because the previous work with human NHR LBDs 
suggest that these conformational changes are related with those that lead to 
coactivation recruitment. [4, 6] 
Validation and Comparison of the Biosensor 
 Our results of biosensor proteins for human, porcine, and sole strains were 
compared with other results that were previously reported for validation purposes 
(Gierach et al., 2011; Hartman et al., 2009; Skretas et al., 2007; Skretas and Wood, 
2005;).  In addition, our results were also compared to studies that performed using a 
yeast-based human ERβ transcriptional assay indicate the following EC50 trend for our 
test compound: E2 > Daidzein > BPA (Escande et al., 2006). [28] Our RPTA trend is 
similar for human: E2 (100) > Daidzein (3.74) > BPA (1.07). Moreover, our results 
indicating that BPA is a weak human ERβ agonist are consistent with extensive 
previous work from other investigations (Kuiper et al., 1998; Shi et al., 2001; Kurosawa 
et al., 2002; Nendza and Wenzel, 2006; Dobbins et al., 2008; Chu et al., 2009). Most 
importantly, EC50 values of our bacterial biosensors assay were also compared to other 
previous studies with yeast assay for BPA and Daidzein: 1.7 µM (bacterial) versus 0.25 
µM (yeast) and 0.36 µM (bacterial) versus 0.15 µM (yeast), respectively (Chu et al., 
2009).[29]  
Due to lack of available data, comparisons of our system with animal models are 
very difficult. However, a comparison was made to some closely related animal species. 
For example, several studies on other piscine species, such as carp (Cyprinus carpio) 
and rainbow trout (oncorhynchus mykiss) were used as a basis when comparing with 
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our sole biosensor results. These assays include direct binding assays on recombinant 
receptors that have been purified, along with transcriptional assays in yeast and human 
cells, and assays based on estrogen-induced secretion of vitellogenin in piscine 
hepatocytes. [32-34] The direct comparison of previously reported and our EC50 of sole 
biosensor is much different; however, consistent with the overall weakness of BPA as a 
ligand with the sole ERβ biosensor. For E2, previously reported EC50 varied between 
50 and 150 nM [33], which is somewhat close with our EC50 variability of 2.7 to 81 for 
sole ERβ biosensor. In the same previously reported study, trout ERβ have shown the 
strongest affinity for E2 when compared with BPA and Daidzein, which were found to 
bind very weakly to the trout ERβ.[33] Note, only human and sole ERβ biosensor were 
able to be compared with other data.  
Overall Trend of Phytoestrogens in our ERβ Biosensors  
 Isoflavones, such as genistein and daidzein, have been identified as 
angiogenesis inhibitors and likely to be found to inhibit the uncontrolled cell growth of 
cancer. This is most likely by inhibiting the activity of substances in the body that 
regulate cell division can cell growth factors. Furthermore, phytoestrogen such as 
genistein and other forms of isoflavones and flavones possess structure similarity to 17-
β-estradiol (E2). Thus, these phytoestrogens such as genistein, daidzein, biochanin A, 
and apigenin may compete with E2 in binding to estrogen receptors. Out of four 
phytoestrogens that were tested, it was expected to observe the lowest EC50 with 
genistein because genistein shows much higher binding affinity toward estrogen 
receptor β in the previous study conducted with phytoestrogens (Kuiper et al., 1998).[30] 
 The estrogenicity precedence from highest to lowest is correlated with RPTA 
precedence from highest percentage to lowest percentage. Because each 
phytoestrogen in each bacterial assay has reported a distinct EC50 value, it is assumed 
that our bacterial biosensor for each species has correctly identified different 
phytoestrogens. The order of RPTA precedence of phytoestrogens for (a) human and 
(b)porcine biosensors are reported as follows: genistein > daidzein > apigenin > 
biochanin A; for (c) sole is reported as follows: genistein > daidzein; for (d) rat: genistein 
> apigenin > daidzein > biochanin A; for (e) cow: genistein > daidzein > apigenin > 
biochanin A; and for (f) zebra fish: daidzein > biochanin A > genistein. Calculated EC50 
values for each different phytoestrogen in each ERβ biosensor were statistically 
determined to be significantly different. Thus, our experimental data suggests that 
genistein was the most potent phytoestrogen for human, porcine, sole, rat, and cow. 
However, EC50 of E2 is reported to be smaller than EC50 of genistein (RPTA 
percentage value for E2 is greater than that of genistein). This suggestion is consist with 
previous investigation by Kuiper et al. in 1998. Our results also suggests that biochanin 
A binds weakly to human, porcine, rat, and cow ERβ biosensor when compared to other 
three phytoestrogen that were being tested.  
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Statistical Analysis of EC50 across Biosensor Species  
 For evaluating the statistical significance between all of ERβ biosensor species, 
experimental EC50 were reported to jmp software and employed Fit Y by X function. A 
simple table is constructed for comparison of p-values with phytoestrogen EC50 values 
compared within each ERβ biosensor. This is shown in table 4 below. For all t-tests and 
tukey test that were conducted, alpha was set at 0.05.  
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 Table 4. Statistical analysis of EC50 of phytoestrogen across multiple species 
 
 
HUMAN Genistein Daidzein Biochanin A Apigenin 
Genistein 0.6377 <0.0001 0.1564
Daidzein 0.6377 <0.0001 0.7058
Biochanin A <0.0001 <0.0001 <0.0001
Apigenin 0.1564 0.7058 <0.0001
PORCINE Genistein Daidzein Biochanin A Apigenin 
Genistein 0.2845 <0.0001 0.0036
Daidzein 0.2845 <0.0001 0.0939
Biochanin A <0.0001 <0.0001 <0.0001
Apigenin 0.0036 0.0939 <0.0001
SOLE Genistein Daidzein Biochanin A Apigenin 
Genistein 0.0004 N/A N/A
Daidzein 0.0004 N/A N/A
Biochanin A N/A N/A N/A
Apigenin N/A N/A N/A
RAT Genistein Daidzein Biochanin A Apigenin 
Genistein 0.0409 <0.0001 0.1566
Daidzein 0.0409 <0.0001 0.4511
Biochanin A <0.0001 <0.0001 <0.0001
Apigenin 0.1566 0.4511 <0.0001
COW Genistein Daidzein Biochanin A Apigenin 
Genistein <0.0001 <0.0001 <0.0001
Daidzein <0.0001 <0.0001 0.08031
Biochanin A <0.0001 <0.0001 <0.0001
Apigenin <0.0001 0.0831 <0.0001
ZFISH Genistein Daidzein Biochanin A Apigenin 
Genistein 0.0014 0.004 N/A
Daidzein 0.0014 0.7428 N/A
Biochanin A 0.004 0.7428 N/A
Apigenin N/A N/A N/A
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Problems, Errors, Shortcomings, and Possible Future Projects 
Possible sources of error may have originated from utilizing materials that have 
been unsuccessfully sterilized; hindered cell growth during overnight and overday 
procedures; temperatures during cell growth may have not been consistent throughout 
the experiment; and incorrect distribution and concentration of ERβ biosensor cells and 
media.    
Some of the EC50 of phytoestrogens were not able to be calculated due to the 
incorrect non-linear regression fitting. This is due to the human error of dispersing 
correct concentration of cells from a reservoir to a 96-microtitler well plate. This is seen 
in graphs where higher logarithmic values of molar concentration displays a lower 
OD600 reading when compared to OD600 readings of the lower logarithmic values of 
molar concentration of testing compounds.  
The zebra fish ERβ biosensor were able to grow in the presence of 
phytoestrogens; however, only the wells in the plate with high concentration of 
phytoestrogen present were able to grow (log (molar concentration) of -7 or higher). 
Thus, this problem may have been avoided if observation were made after 16-24 hour 
interval. 
The sole ERβ biosensor was much difficult to derive a definite conclusion, as 
OD600 values were unusually high. This is because we assume that sole LBD may be 
somewhat unfolded in the absence of any test compounds. As a result, unfolded LBD 
can destabilize the intein and allow higher background activity of the TS enzyme; thus, 
high OD600 readings may be observed. All of the OD600 readings with corresponding 
test compounds of all of strains performed in this study are reported in appendix I.   
Possible future project may consist of finding more studies on binding assays 
with unknown estrogenic compounds, testing our bacterial assay with other endocrine 
disrupting compounds, and more.  
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Appendix I 
Reported OD600 values 
 
 
 
 
HUMAN 1 2 3 4 5 6 7 8 9 10 11 12
NO 0.073 0.076 0.073 0.072 0.076 0.082 0.077 0.077 0.078 0.078 0.076 0.075
E2 0.285 0.272 0.259 0.245 0.234 0.2 0.137 0.101 0.086 0.08 0.078 0.083
GEN 0.29 0.272 0.261 0.238 0.205 0.141 0.106 0.086 0.08 0.083 0.082 0.08
DAID 0.215 0.233 0.209 0.19 0.123 0.094 0.087 0.087 0.089 0.081 0.085 0.089
BIOA 0.139 0.127 0.102 0.096 0.093 0.088 0.089 0.084 0.086 0.083 0.081 0.08
TRI 0.136 0.174 0.163 0.121 0.102 0.095 0.091 0.09 0.088 0.089 0.088 0.084
DMSO 0.108 0.082 0.083 0.081 0.086 0.087 0.087 0.09 0.19 0.083 0.087 0.085
GEN 0.274 0.291 0.267 0.285 0.21 0.147 0.097 0.09 0.081 0.084 0.081 0.079
HUMAN 1 2 3 4 5 6 7 8 9 10 11 12
NO 0.079 0.071 0.073 0.073 0.08 0.083 0.084 0.083 0.086 0.083 0.084 0.074
E2 0.461 0.464 0.404 0.394 0.382 0.384 0.403 0.195 0.117 0.095 0.091 0.077
GEN 0.438 0.422 0.45 0.388 0.389 0.434 0.202 0.125 0.099 0.093 0.09 0.082
DAID 0.491 0.38 0.406 0.445 0.285 0.133 0.102 0.097 0.095 0.093 0.091 0.087
BIOA 0.317 0.303 0.147 0.111 0.102 0.097 0.095 0.095 0.098 0.09 0.087 0.079
TRI 0.33 0.483 0.47 0.321 0.157 0.109 0.101 0.097 0.102 0.096 0.086 0.08
DMSO 0.21 0.078 0.085 0.097 0.09 0.093 0.096 0.094 0.389 0.086 0.084 0.075
GEN 0.507 0.445 0.404 0.456 0.459 0.444 0.181 0.112 0.085 0.082 0.076 0.075
HUMAN 1 2 3 4 5 6 7 8 9 10 11 12
NO 0.073 0.076 0.076 0.078 0.09 0.091 0.089 0.089 0.092 0.09 0.092 0.077
E2 0.5 0.51 0.439 0.425 0.424 0.425 0.463 0.242 0.135 0.103 0.097 0.08
GEN 0.471 0.461 0.482 0.429 0.421 0.469 0.258 0.143 0.108 0.098 0.093 0.082
DAID 0.522 0.423 0.445 0.481 0.367 0.157 0.111 0.105 0.1 0.098 0.094 0.079
BIOA 0.378 0.387 0.176 0.121 0.108 0.104 0.101 0.101 0.108 0.096 0.092 0.091
TRI 0.389 0.512 0.499 0.402 0.189 0.119 0.105 0.102 0.113 0.097 0.098 0.087
DMSO 0.253 0.077 0.086 0.098 0.093 0.095 0.101 0.1 0.428 0.09 0.086 0.076
GEN 0.552 0.477 0.437 0.492 0.496 0.5 0.224 0.126 0.09 0.087 0.077 0.076
COW 1 2 3 4 5 6 7 8 9 10 11 12
NO 0.069 0.07 0.071 0.074 0.069 0.07 0.068 0.068 0.073 0.071 0.072 0.067
E2 0.339 0.28 0.224 0.117 0.089 0.083 0.072 0.074 0.074 0.073 0.072 0.07
GEN 0.37 0.307 0.295 0.268 0.222 0.169 0.108 0.089 0.085 0.079 0.08 0.074
DAID 0.237 0.241 0.236 0.181 0.119 0.096 0.086 0.083 0.092 0.086 0.087 0.08
BIOA 0.179 0.166 0.115 0.091 0.086 0.087 0.09 0.085 0.083 0.084 0.082 0.075
TRI 0.172 0.191 0.165 0.129 0.106 0.096 0.087 0.083 0.084 0.08 0.077 0.076
DMSO 0.116 0.077 0.079 0.079 0.086 0.086 0.084 0.084 0.193 0.084 0.08 0.082
BPA 0.149 0.115 0.083 0.077 0.08 0.078 0.091 0.077 0.081 0.074 0.075 0.072
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COW 1 2 3 4 5 6 7 8 9 10 11 12
NO 0.086 0.068 0.072 0.072 0.075 0.073 0.068 0.069 0.073 0.073 0.073 0.067
E2 0.503 0.456 0.44 0.388 0.125 0.091 0.073 0.073 0.072 0.075 0.072 0.067
GEN 0.478 0.419 0.436 0.426 0.419 0.433 0.249 0.134 0.101 0.09 0.089 0.075
DAID 0.452 0.402 0.432 0.429 0.381 0.158 0.108 0.101 0.107 0.094 0.093 0.083
BIOA 0.495 0.414 0.336 0.148 0.114 0.105 0.101 0.097 0.091 0.095 0.09 0.073
TRI 0.445 0.45 0.484 0.426 0.217 0.129 0.107 0.096 0.101 0.085 0.083 0.075
DMSO 0.327 0.077 0.08 0.084 0.093 0.097 0.092 0.092 0.436 0.09 0.078 0.081
BPA 0.443 0.36 0.106 0.081 0.077 0.077 0.09 0.076 0.081 0.072 0.07 0.069
COW 1 2 3 4 5 6 7 8 9 10 11 12
NO 0.088 0.056 0.074 0.074 0.077 0.075 0.07 0.073 0.075 0.073 0.073 0.067
E2 0.523 0.519 0.475 0.438 0.141 0.097 0.075 0.076 0.075 0.077 0.073 0.067
GEN 0.514 0.452 0.472 0.471 0.462 0.469 0.3 0.15 0.11 0.094 0.091 0.076
DAID 0.493 0.437 0.466 0.47 0.444 0.181 0.121 0.113 0.113 0.099 0.099 0.083
BIOA 0.522 0.437 0.403 0.168 0.131 0.111 0.106 0.102 0.093 0.097 0.093 0.079
TRI 0.477 0.479 0.525 0.467 0.255 0.142 0.117 0.104 0.108 0.089 0.091 0.075
DMSO 0.38 0.08 0.085 0.094 0.097 0.103 0.098 0.097 0.492 0.092 0.082 0.083
BPA 0.449 0.185 0.117 0.082 0.077 0.071 0.115 0.045 0.047 0.043 0.042 0.07
PORCINE 1 2 3 4 5 6 7 8 9 10 11 12
NO 0.048 0.05 0.052 0.052 0.056 0.052 0.053 0.05 0.055 0.052 0.051 0.052
E2 0.189 0.21 0.21 0.209 0.183 0.153 0.099 0.073 0.065 0.06 0.057 0.054
GEN 0.237 0.24 0.209 0.202 0.163 0.102 0.072 0.068 0.063 0.06 0.059 0.058
DAID 0.152 0.171 0.15 0.102 0.08 0.072 0.063 0.064 0.06 0.06 0.064 0.06
BIOA 0.11 0.102 0.076 0.068 0.068 0.062 0.06 0.061 0.06 0.062 0.058 0.058
TRI 0.112 0.115 0.1 0.074 0.07 0.072 0.063 0.062 0.066 0.059 0.06 0.058
DMSO 0.08 0.053 0.056 0.057 0.06 0.061 0.061 0.059 0.104 0.057 0.057 0.061
E2 0.178 0.149 0.115 0.089 0.067 0.063 0.06 0.06 0.057 0.055 0.056 0.056
PORCINE 1 2 3 4 5 6 7 8 9 10 11 12
NO 0.047 0.048 0.051 0.053 0.053 0.052 0.053 0.051 0.053 0.053 0.052 0.051
E2 0.491 0.451 0.455 0.448 0.452 0.458 0.322 0.1 0.067 0.063 0.058 0.053
GEN 0.478 0.457 0.51 0.488 0.462 0.38 0.09 0.069 0.063 0.061 0.06 0.055
DAID 0.456 0.455 0.432 0.366 0.122 0.078 0.065 0.065 0.059 0.06 0.064 0.055
BIOA 0.285 0.342 0.113 0.07 0.068 0.066 0.063 0.062 0.061 0.061 0.059 0.056
TRI 0.288 0.443 0.343 0.129 0.078 0.08 0.063 0.062 0.064 0.058 0.058 0.057
DMSO 0.114 0.055 0.056 0.057 0.057 0.06 0.06 0.062 0.32 0.059 0.058 0.057
DAID 0.468 0.432 0.48 0.24 0.078 0.065 0.06 0.059 0.055 0.054 0.053 0.051
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PORCINE 1 2 3 4 5 6 7 8 9 10 11 12
NO 0.047 0.052 0.051 0.053 0.054 0.053 0.055 0.05 0.052 0.053 0.051 0.051
E2 0.562 0.498 0.503 0.497 0.494 0.484 0.417 0.115 0.068 0.063 0.058 0.054
GEN 0.516 0.501 0.56 0.523 0.496 0.482 0.099 0.071 0.064 0.061 0.059 0.057
DAID 0.474 0.497 0.475 0.457 0.146 0.081 0.066 0.067 0.059 0.058 0.064 0.057
BIOA 0.356 0.431 0.132 0.071 0.069 0.067 0.062 0.063 0.063 0.06 0.059 0.057
TRI 0.374 0.472 0.438 0.158 0.082 0.084 0.065 0.062 0.065 0.059 0.059 0.059
DMSO 0.13 0.057 0.056 0.056 0.057 0.059 0.059 0.061 0.411 0.057 0.057 0.056
E2 0.514 0.484 0.491 0.305 0.085 0.067 0.06 0.06 0.055 0.053 0.054 0.051
RAT 1 2 3 4 5 6 7 8 9 10 11 12
NO 0.081 0.084 0.085 0.091 0.108 0.097 0.094 0.096 0.092 0.089 0.086 0.087
E2 0.197 0.223 0.186 0.126 0.102 0.095 0.092 0.088 0.087 0.088 0.088 0.088
GEN 0.228 0.222 0.203 0.193 0.169 0.137 0.115 0.105 0.093 0.093 0.091 0.094
DAID 0.159 0.163 0.146 0.123 0.121 0.103 0.1 0.099 0.097 0.095 0.1 0.095
BIOA 0.125 0.116 0.098 0.108 0.093 0.097 0.096 0.098 0.093 0.091 0.087 0.098
TRI 0.115 0.118 0.116 0.106 0.102 0.1 0.098 0.096 0.096 0.094 0.095 0.093
DMSO 0.101 0.087 0.09 0.093 0.104 0.096 0.094 0.095 0.126 0.089 0.089 0.09
BPA 0.113 0.103 0.089 0.087 0.09 0.09 0.091 0.09 0.09 0.088 0.091 0.09
RAT 1 2 3 4 5 6 7 8 9 10 11 12
NO 0.157 0.123 0.119 0.138 0.186 0.153 0.143 0.152 0.135 0.124 0.12 0.112
E2 0.482 0.519 0.457 0.371 0.196 0.142 0.129 0.12 0.117 0.109 0.112 0.114
GEN 0.496 0.458 0.46 0.468 0.463 0.431 0.26 0.184 0.137 0.128 0.122 0.118
DAID 0.455 0.446 0.452 0.353 0.293 0.175 0.157 0.144 0.133 0.128 0.148 0.121
BIOA 0.3 0.286 0.194 0.169 0.15 0.144 0.14 0.141 0.124 0.119 0.117 0.129
TRI 0.256 0.382 0.284 0.208 0.173 0.147 0.134 0.132 0.138 0.126 0.112 0.109
DMSO 0.205 0.112 0.115 0.127 0.157 0.133 0.127 0.128 0.329 0.112 0.106 0.101
BPA 0.346 0.214 0.116 0.103 0.105 0.104 0.109 0.108 0.104 0.103 0.096 0.094
SOLE 1 2 3 4 5 6 7 8 9 10 11 12
NO 0.307 0.349 0.374 0.445 0.41 0.38 0.389 0.389 0.406 0.444 0.41 0.445
E2 0.525 0.512 0.506 0.507 0.496 0.476 0.44 0.426 0.427 0.425 0.434 0.479
GEN 0.491 0.492 0.489 0.481 0.458 0.457 0.434 0.441 0.429 0.432 0.428 0.463
DAID 0.434 0.452 0.44 0.419 0.43 0.416 0.439 0.436 0.427 0.437 0.437 0.423
BIOA 0.417 0.438 0.458 0.443 0.447 0.474 0.441 0.452 0.451 0.428 0.424 0.429
TRI 0.358 0.46 0.456 0.434 0.438 0.467 0.435 0.455 0.395 0.409 0.417 0.417
DMSO 0.421 0.414 0.43 0.435 0.453 0.461 0.437 0.444 0.466 0.45 0.431 0.425
E2 0.507 0.51 0.481 0.488 0.479 0.464 0.422 0.44 0.433 0.407 0.452 0.428
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SOLE 1 2 3 4 5 6 7 8 9 10 11 12
NO 0.504 0.495 0.499 0.519 0.515 0.498 0.504 0.447 0.528 0.535 0.534 0.54
E2 0.58 0.578 0.525 0.52 0.519 0.505 0.485 0.48 0.474 0.481 0.521 0.575
GEN 0.587 0.535 0.526 0.499 0.491 0.49 0.483 0.477 0.48 0.481 0.493 0.524
DAID 0.529 0.48 0.472 0.473 0.502 0.471 0.483 0.499 0.476 0.476 0.484 0.49
BIOA 0.526 0.479 0.481 0.478 0.485 0.52 0.475 0.484 0.484 0.484 0.544 0.539
TRI 0.437 0.505 0.541 0.488 0.488 0.523 0.478 0.487 0.476 0.482 0.521 0.513
DMSO 0.534 0.474 0.475 0.49 0.539 0.487 0.486 0.482 0.508 0.493 0.496 0.494
DAID 0.578 0.583 0.535 0.534 0.524 0.511 0.489 0.486 0.529 0.499 0.509 0.49
SOLE 1 2 3 4 5 6 7 8 9 10 11 12
NO 0.522 0.514 0.512 0.528 0.523 0.517 0.522 0.472 0.54 0.542 0.548 0.56
E2 0.608 0.597 0.547 0.539 0.542 0.538 0.508 0.503 0.498 0.504 0.534 0.602
GEN 0.603 0.568 0.548 0.517 0.516 0.517 0.509 0.502 0.508 0.508 0.525 0.547
DAID 0.551 0.511 0.493 0.496 0.527 0.497 0.514 0.529 0.5 0.51 0.522 0.516
BIOA 0.539 0.509 0.511 0.507 0.507 0.546 0.504 0.508 0.51 0.521 0.569 0.558
TRI 0.454 0.53 0.569 0.514 0.512 0.548 0.506 0.514 0.503 0.511 0.535 0.526
DMSO 0.552 0.496 0.493 0.516 0.561 0.517 0.513 0.509 0.541 0.522 0.529 0.516
DAID 0.602 0.609 0.56 0.561 0.552 0.538 0.516 0.513 0.552 0.513 0.531 0.511
ZFISH 1 2 3 4 5 6 7 8 9 10 11 12
NO 0.085 0.086 0.095 0.091 0.096 0.094 0.086 0.084 0.095 0.083 0.08 0.079
E2 0.394 0.31 0.22 0.132 0.103 0.097 0.089 0.091 0.091 0.088 0.081 0.08
GEN 0.277 0.25 0.177 0.131 0.106 0.098 0.097 0.089 0.1 0.095 0.093 0.088
DAID 0.116 0.104 0.109 0.102 0.095 0.094 0.091 0.088 0.095 0.091 0.093 0.087
BIOA 0.11 0.102 0.107 0.095 0.092 0.092 0.095 0.086 0.092 0.091 0.089 0.088
TRI 0.092 0.092 0.097 0.103 0.097 0.099 0.091 0.09 0.091 0.09 0.089 0.085
DMSO 0.099 0.093 0.102 0.098 0.095 0.096 0.092 0.092 0.111 0.091 0.09 0.086
BPA 0.1 0.101 0.103 0.092 0.096 0.089 0.088 0.087 0.092 0.089 0.087 0.091
ZFISH 1 2 3 4 5 6 7 8 9 10 11 12
NO 0.105 0.102 0.122 0.122 0.13 0.125 0.112 0.104 0.128 0.113 0.105 0.091
E2 0.527 0.473 0.467 0.267 0.143 0.118 0.109 0.098 0.114 0.109 0.098 0.091
GEN 0.503 0.422 0.413 0.403 0.205 0.142 0.124 0.114 0.126 0.123 0.113 0.096
DAID 0.196 0.224 0.178 0.145 0.125 0.126 0.122 0.115 0.115 0.111 0.106 0.095
BIOA 0.136 0.144 0.139 0.128 0.129 0.125 0.118 0.114 0.114 0.112 0.108 0.093
TRI 0.098 0.115 0.12 0.124 0.11 0.112 0.109 0.106 0.11 0.109 0.105 0.091
DMSO 0.118 0.105 0.125 0.12 0.115 0.115 0.113 0.113 0.196 0.108 0.104 0.094
BPA 0.122 0.121 0.116 0.103 0.102 0.106 0.104 0.098 0.1 0.097 0.091 0.087
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Human
&Cow 1 2 3 4 5 6 7 8 9 10 11 12
GEN 0.166 0.039 0.036 0.037 0.038 0.036 0.036 0.038 0.036 0.038 0.036 0.036
DAID 0.065 0.038 0.039 0.036 0.037 0.055 0.037 0.037 0.038 0.04 0.038 0.037
BIOA 0.077 0.039 0.037 0.037 0.037 0.038 0.036 0.036 0.036 0.038 0.038 0.038
TRI 0.041 0.045 0.041 0.039 0.038 0.037 0.039 0.036 0.037 0.039 0.037 0.038
GEN 0.512 0.587 0.571 0.618 0.615 0.585 0.573 0.512 0.521 0.289 0.159 0.117
DAID 0.498 0.493 0.544 0.543 0.516 0.34 0.198 0.146 0.11 0.12 0.131 0.114
BIOA 0.422 0.51 0.444 0.269 0.166 0.121 0.072 0.063 0.067 0.059 0.059 0.09
TRI 0.369 0.419 0.397 0.333 0.212 0.089 0.124 0.099 0.053 0.051 0.074 0.082
PIG&RAT 1 2 3 4 5 6 7 8 9 10 11 12
GEN 0.42 0.508 0.506 0.482 0.569 0.478 0.609 0.557 0.471 0.296 0.178 0.105
DAID 0.603 0.533 0.566 0.566 0.551 0.427 0.23 0.157 0.115 0.109 0.104 0.102
BIOA 0.43 0.518 0.429 0.265 0.154 0.122 0.115 0.126 0.108 0.113 0.118 0.104
TRI 0.43 0.562 0.525 0.388 0.245 0.148 0.127 0.116 0.111 0.119 0.114 0.108
GEN 0.448 0.585 0.608 0.549 0.569 0.518 0.504 0.463 0.368 0.28 0.208 0.185
DAID 0.409 0.525 0.442 0.361 0.381 0.303 0.235 0.207 0.197 0.19 0.197 0.176
BIOA 0.31 0.341 0.281 0.217 0.225 0.212 0.221 0.208 0.187 0.2 0.197 0.19
TRI 0.275 0.272 0.244 0.198 0.199 0.196 0.194 0.189 0.178 0.194 0.181 0.175
Sole&Zfish 1 2 3 4 5 6 7 8 9 10 11 12
GEN 0.936 0.911 0.858 0.854 0.727 0.791 0.961 0.746 0.805 0.647 0.797 0.705
DAID 0.82 0.855 0.743 0.746 0.767 0.886 0.852 0.789 0.8 0.87 0.809 0.77
BIOA 0.757 0.694 0.596 0.622 0.654 0.691 0.727 0.747 0.76 0.823 0.759 0.712
TRI 0.847 0.797 0.935 0.745 0.714 0.704 0.761 0.915 0.832 0.917 0.854 0.811
GEN 0.686 0.61 0.533 0.381 0.342 0.276 0.267 0.194 0.234 0.194 0.187 0.198
DAID 0.304 0.273 0.203 0.172 0.192 0.17 0.164 0.203 0.229 0.201 0.198 0.203
BIOA 0.176 0.221 0.162 0.167 0.145 0.143 0.181 0.17 0.158 0.179 0.197 0.227
TRI 0.155 0.154 0.139 0.116 0.129 0.11 0.116 0.153 0.201 0.229 0.216 0.155
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Appendix II 
Calculated EC50 values 
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Appendix III 
Statistical Analysis on jmp 10 software 
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